Literature DB >> 33831950

The effect of intermittent energy restriction on weight loss and diabetes risk markers in women with a history of gestational diabetes: a 12-month randomized control trial.

Kristy L Gray1,2, Peter M Clifton1,2, Jennifer B Keogh1,2.   

Abstract

BACKGROUND: Weight loss after gestational diabetes (GDM) can prevent or delay the onset of type 2 diabetes. Intermittent energy restriction (IER) may offer an alternative to continuous energy restriction (CER) for weight loss.
OBJECTIVES: We compared the effects of IER (2 days per week) to daily CER over 12 mo on weight loss and diabetes risk markers in overweight women with previous GDM.
METHODS: Overweight females (n = 121) ≥18 y were randomized 1:1 to either IER [2-d 500 kcal (2100 kJ); n = 61] or CER [1500 kcal (6000 kJ); n = 60] in this 12-mo noninferiority trial.
RESULTS: The trial was completed by 62 participants with a median age of 39.6 y [Quartile (Q) 1 to Quartile 3, 34.9 to 43.9 y] with a median BMI of 32.6 kg/m2 (Q1 to Q3, 28.5 to 37.9 kg/m2) at a median of 2.9 y after GDM (Q1 to Q3, 2.1 to 6.4 y; 49% attrition; IER n = 29; CER n = 30; P = 0.8). The mean ± SD weight loss was significant over time (P < 0.001) but not by diet group (IER -4.8 ± 5.0 kg; CER -3.2 ± 5.0; P = 0.2). The mean between-group difference was -1.6 kg (95% CI: -4.2 to 1.0 kg; P = 0.2). There were no significant between-group differences in change in HbA1c, fasting plasma glucose, fasting serum insulin, HOMA-IR or 2-h oral glucose tolerance at 12 mo (p>0.05). The trial was registered at https://www.anzctr.org.au/ (ACTRN12617001476325).
CONCLUSIONS: IER produces comparable weight loss to CER over 12 mo in overweight women with previous GDM. The high dropout rate in this study is a limitation in the interpretation of these results. Larger studies are needed to confirm noninferiority of IER compared to CER.
© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.

Entities:  

Keywords:  diabetes prevention; gestational diabetes; intermittent energy restriction; intermittent fasting; overweight; weight loss; women

Year:  2021        PMID: 33831950     DOI: 10.1093/ajcn/nqab058

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  4 in total

Review 1.  Effect of Intermittent Fasting on Reproductive Hormone Levels in Females and Males: A Review of Human Trials.

Authors:  Sofia Cienfuegos; Sarah Corapi; Kelsey Gabel; Mark Ezpeleta; Faiza Kalam; Shuhao Lin; Vasiliki Pavlou; Krista A Varady
Journal:  Nutrients       Date:  2022-06-03       Impact factor: 6.706

2.  Randomized controlled trial of once-per-week intermittent fasting for health improvement: the WONDERFUL trial.

Authors:  Ciera L Bartholomew; Joseph B Muhlestein; Heidi T May; Viet T Le; Oxana Galenko; Kelly Davis Garrett; Cherie Brunker; Ramona O Hopkins; John F Carlquist; Kirk U Knowlton; Jeffrey L Anderson; Bruce W Bailey; Benjamin D Horne
Journal:  Eur Heart J Open       Date:  2021-09-03

Review 3.  NADH/NAD+ Redox Imbalance and Diabetic Kidney Disease.

Authors:  Liang-Jun Yan
Journal:  Biomolecules       Date:  2021-05-14

4.  Preferential Metabolic Improvement by Intermittent Fasting in People with Elevated Baseline Red Cell Distribution Width: A Secondary Analysis of the WONDERFUL Randomized Controlled Trial.

Authors:  Benjamin D Horne; Joseph B Muhlestein; Heidi T May; Viet T Le; Tami L Bair; Sterling T Bennett; Kirk U Knowlton; Jeffrey L Anderson
Journal:  Nutrients       Date:  2021-12-09       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.